ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 400

Clinical Utility of 14-3-3η in the Evaluation of Inflammatory Arthritis

Lance Feller1, Paul Tuttle IV2 and Terry L. Moore3, 1Rheumatology, Saint Louis University, St. Louis, MO, 2Rheumatology, Saint Louis University, Saint Louis, MO, 3Internal Medicine/Rheumatology, Saint Louis University, Saint Louis, MO

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Diagnostic Tests, inflammatory arthritis, juvenile idiopathic arthritis (JIA) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose

14-3-3 proteins are chaperonins found in all eukaryotic cells. There are multiple isoforms which are thought to be involved in intracellular signaling and transcription regulation. Among their targets are phosphatases, kinases and transmembrane receptors. There are seven known isoforms in mammals. Recent work has implicated the η (Eta) isoform as having diagnostic potential in inflammatory arthritis. In this study we investigated the utility of measuring 14-3-3η when evaluating of inflammatory arthritis.

Methods

Measurements of 14-3-3η were obtained during evaluation of joint pain in patients presenting between July 2013 and May of 2014. Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (anti-CCP Ab) were measured. Joint imaging was evaluated for erosive changes. A chart review was later conducted to evaluate the utility of standard measures versus 14-3-3η.

 Results

120 patients were evaluated. 21 had RA, 8 had juvenile idiopathic arthritis (JIA), and 6 had psoriatic arthritis (PsA). 30 patients had connective tissue disease (CTD). 10 had fibromyalgia (FMS), 3 had monoclonal gammopathies, 1 had enteropathic arthritis, and 1 had erosive osteoarthritis (OA). 8 had only OA, 2 had benign hypermobility syndrome, 1 had amyopathic dermatomyositis, 2 had celiac disease, and 2 had crystal induced arthropathies. 7 were antinuclear antibody (ANA) positive without synovitis or CTD. 3 patients had granulomatosis with polyangiitis, 2 had suspected PsA, 2 had chronic urticaria, and 11 had no associated condition.

Of the 21 RA patients, 18 were RF positive, 16 were anti-CCP Ab positive, and 16 were 14-3-3η positive. All 16 14-3-3η positive patients with RA were RF positive. 9 had joint erosions, of which 8 were RF, anti-CCP Ab and 14-3-3η positive. 14-3-3η was 76.2% sensitive for RA, and 89% specific. Its positive predictive value (PPV) was 61.5%, and negative predictive value (NPV) was 94.2%. 4 of the 8 JIA patients were 14.3.3η and RF positive. 4 were also anti-CCP Ab positive, of which 2 had measurable 14-3-3η. 3 JIA patients had joint erosions. When JIA and RA were considered together, the sensitivity and specificity of 14-3-3η was 68.9 and 89% respectively, while PPV and NPV were 66.7 and 90%. The correlation of 14-3-3η and RF titers in RA was 0.63 (p<0.01) and 0.65 (p<0.001) in the combined RA/JIA cohort.

All 6 patients with PsA were seronegative. 2 had joint erosions.

30 patients had CTD; 6 were RF positive, 2 were anti-CCP Ab positive, and 5 were 14-3-3η positive. 3 of the five 14-3-3η positive patients also produced RF, while 1 had anti-CCP Ab.

All FMS patients were seronegative. Of the 8 patients with purely OA, 1 had 14-3-3η. 1 patient with celiac disease had 14-3-3η. 1 patient with a positive ANA and joint pain had 14-3-3η. 1 patient with joint pain and no evidence of synovitis produced 14-3-3η.

Of the 17 patients with RF without RA, 10 were positive for 14-3-3η, while 6 produced anti-CCP Ab.

Conclusion

14-3-3η protein titers are associated with RA. Their general trend follows RF. Based upon the results from our study, 14-3-3η is both sensitive and specific for RA, with value in evaluating JIA as well. A larger sample size is necessary to evaluate utility with JIA.


Disclosure:

L. Feller,
None;

P. Tuttle IV,
None;

T. L. Moore,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-utility-of-14-3-3%ce%b7-in-the-evaluation-of-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology